August 25, 2016
Emerging Treatment Options to be Presented at 21st Annual Perspectives in Thoracic Oncology Conference
Imedex, LLC to Accredit and Organize the Annual Conference
(New York, NY) — The 21st Annual Perspectives in Thoracic Oncology, a comprehensive 2-day conference highlighting the most relevant developments in lung cancer, will be an unparalleled educational experience for the 200+ healthcare professionals expected to attend the conference on November 18-19, 2016 in New York, New York at The Westin New York at Times Square.
“This conference provides a forum to update your knowledge in the field of thoracic oncology, confirm your current practice, and receive valuable take-home information on exciting new screening and staging modalities, management approaches and emerging treatment options,” said conference chair Corey J. Langer, MD, FACP, Director, Thoracic Oncology at the Abramson Cancer Center of the University of Pennsylvania.
Many of the clinical updates this year will center around immunotherapy, given the recent FDA approvals of immune checkpoint inhibitors pembrolizumab and nivolumab for advanced NSCLC. Also, a recent PubMed search of ‘immunotherapy and lung cancer’ produced over 150 publications during the past 12 months; this is a reflection of the exploding field of immunotherapy in the management of this disease. In addition to presentations on primary treatment, this year’s meeting will also include provocative discussion on supportive care topics such as managing cachexia and doctor-patient communication around end-of-life decisions. “The meeting will give practicing oncologists a ‘state-of-the-art’ platform from which to move forward in effectively treating patients with thoracic cancer,” said Dr. Langer.
Clinicians who have attended this conference in years past echo the comments of Dr. Langer, calling it a “informative and focused meeting with well-selected faculty” and being “very satisfied with the content and interactivity.” Dr. Langer’s Expert Perspectives summary of the insights, science, and key takeaways discussed at last year’s 20th Congress is available at http://bit.ly/2bObRgi http://bit.ly/2bObRgi
“The conference’s format allows faculty and attendees to gain greater understanding of the treatment challenges that community oncologists face in daily practice. Along with interactive presentations, sessions will feature debates with faculty highlighting two different perspectives of a clinical challenge, as well as panel discussions in which faculty share their own evidence-based expert opinions,” said Chris Bolwell, COO of Imedex. An attendee at the 2015 conference commented that “the format of 20-minute presentations, in groups of 3 or 4 followed by panel discussion, is by far the best format of any conference I have attended”.
This year marks the 21st annual conference, and will be chaired for the 11th consecutive year by Corey J. Langer, MD, FACP. As in the past, the meeting will be certified and organized by Imedex, an industry leader in providing oncology CME programs in a live conference setting and online. Imedex is pleased to once again be partnering with the conference chairmen and faculty to provide this educational program to the thoracic oncology community.To register or for more information, please visit www.perspectivesinthoraciccancer.com
Imedex is the industry leader in developing and delivering independent, accredited health care education. The Company’s programs, specializing in oncology, hematology, and gastroenterology, are provided through live events around the world, as well as effective online educational opportunities for on the go healthcare providers.
Imedex’s high quality scientific programming translates the latest research into clinically-relevant information. Our activities address the needs of healthcare professionals inundated by information through exceptional organization and outstanding educational value, with a proven sustained impact on patient care.
Imedex provides over 50,000 e-learning experiences annually and its live conferences have interfaced with more than 100,000 attendees from over 100 countries, since 2001. The Company has a global footprint and operates in the United States, Europe, and Asia.
At Imedex, education is the best medicine®. For more information on Imedex and upcoming conferences, visit us online at www.imedex.com or on our e-learning center at http://elc.imedex.com or via email at email@example.com
Upcoming live events include:
US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes
August 26-27, 2016
Lymphoma & Myeloma 2016: An International Congress on Hematologic Malignancies
October 13-15, 2016
New York, New York
Lymphoma National Grand Rounds
October 16, 2016
New York, New York
21st Annual Perspectives in Thoracic Oncology
Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation of America’s Clinical & Research Conference
November 18-19, 2016
New York, New York
December 8-10, 2016
ESMO 19th World Congress on Gastrointestinal Cancer
28 June - 1 July 2017